MODERN APPROACHES TO THE USE OF INOTROPIC SUPPORT IN PATIENTS WITH CARDIOGENIC SHOCK: IMPACT ON HEMODYNAMICS AND CLINICAL OUTCOMES
Abstract
Cardiogenic shock is one of the most severe complications of acute and chronic cardiovascular diseases and is characterized by a critical reduction in cardiac output, tissue hypoperfusion, and high mortality. Despite advances in modern intensive care, mortality associated with cardiogenic shock remains high. One of the key therapeutic strategies is the use of inotropic agents aimed at improving myocardial contractility and restoring adequate systemic hemodynamics. This study reviews current opportunities for inotropic support in patients with cardiogenic shock, analyzes the mechanisms of action of the main inotropic agents, and evaluates their effects on hemodynamic parameters, organ perfusion, and clinical outcomes. It is demonstrated that the rational use of inotropic therapy can increase cardiac output, stabilize the patient's condition, and improve treatment outcomes when applied through an individualized approach and careful monitoring of hemodynamic parameters.
References
1. McDonagh T.A., Metra M., Adamo M., et al. 2023 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure. European Heart Journal. 2023;44(4):359–372.
2. Thiele H., Ohman E.M., de Waha-Thiele S., Zeymer U., Desch S. Management of Cardiogenic Shock Complicating Myocardial Infarction: An Update. European Heart Journal. 2024;45(2):123–145.
3. Van Diepen S., Katz J.N., Albert N.M., et al. Contemporary Management of Cardiogenic Shock. Circulation. 2023;147(8):648–671.
4. Tehrani B.N., Truesdell A.G., Psotka M.A., et al. A Standardized and Comprehensive Approach to the Management of Cardiogenic Shock. Journal of the American College of Cardiology. 2022;79(11):1089–1106.
5. Mebazaa A., Tolppanen H., Mueller C., et al. Acute Heart Failure and Cardiogenic Shock: Contemporary Treatment Strategies. Intensive Care Medicine. 2022;48(5):523–542.
6. Harjola V.P., Lassus J., Sionis A., et al. Clinical Picture and Risk Prediction of Cardiogenic Shock. European Journal of Heart Failure. 2021;23(4):593–602.
7. Levy B., Clere-Jehl R., Legras A., et al. Epinephrine versus Norepinephrine for Cardiogenic Shock after Acute Myocardial Infarction. Journal of the American College of Cardiology. 2021;78(7):658–667.
8. Mebazaa A., Yilmaz M.B., Levy P., et al. Recommendations on Pre-hospital and Early Hospital Management of Acute Heart Failure and Cardiogenic Shock. European Journal of Heart Failure. 2021;23(1):76–95.
9. Krylov V.V., Petrikov S.S. Intensive Care of Critical Conditions in Cardiology. Moscow: GEOTAR-Media; 2023. 368 p.
10. Ramazanova Z., Ibragimov N. (2026). Modern approaches to the use of antioxidants in cerebral ischemia and traumatic brain injury. Central Asian Journal of Medicine, 1(8), 174-179. https://journals.tnmu.uz/index.php/cajm/article/view/3628
11. Ramazanova Z., Ibragimov N. Therapeutic role of 3-methyl-1-phenyl-2-pyrazolin-5-one in patients with traumatic brain injury and acute cerebral failure syndrome //american journal of applied medical science. – 2025. – Т. 3. – №. 9. – С. 70-77.
12. Д. М. Сабиров, А. К. Койиров, Х. И. Саттаров, М. Б. Красненкова наружная контрпульсация в комплексном лечении пациентов с острой сердечной недостаточностью // Вестник экстренной медицины. 2016. №4. URL: https://cyberleninka.ru/article/n/naruzhnaya-kontrpulsatsiya-v-kompleksnom-lechenii-patsientov-s-ostroy-serdechnoy-nedostatochnostyu (дата обращения: 19.05.2026).
13. Bagnenko S.F., Miroshnichenko A.G., Shlyakhto E.V. Emergency Cardiology and Intensive Care of Cardiogenic Shock. Saint Petersburg: SpetsLit; 2022. 312 p.
